Live feed
Filing
SC 13D/A
SC 13D/A0001193125-19-000582·Deciphera Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
DECIPHERA PHARMACEUTICALS IN
Security class unavailable · CUSIP: 24344T101
Event date: 2018-10-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-000582
- Form type
- SC 13D/A
- Filer
- Deciphera Pharmaceuticals, Inc.
- CIK
- CIK 1654151
- Filed
- Jan 02, 2019
- Reporting period
- Oct 31, 2018
- Description
- Schedule 13D beneficial ownership